MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MH-19-0031971
Maypharm Lifesciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15.79 Cr
▲ 33% YoY
Net profit · FY 2025
₹1.58 Cr
Net margin 10%
EBITDA · FY 2025
₹2.38 Cr
EBITDA margin 15.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
4
As per MCA filings
Active GSTINs
1
GST registered
About Maypharm Lifesciences Private Limited
Data last updated:
Maypharm Lifesciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2016PTC273231. Its GSTIN is 27AALCM2177J1Z2 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sameer Sidhram Kolhe (Managing Director) and Ameya Anant Budukh.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 87 Vishal Industrial Estate Opp Ceat Tyres Village Bhandup West Mumbai 400078 Mh In, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.79 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹1.58 Cr (net margin 10%) and EBITDA of ₹2.38 Cr (EBITDA margin 15.1%). Revenue has grown at a compounded annual rate (CAGR) of 238% over three years and 123% over five years.
The company is associated with 1 brand: Maypharm Life Sciences.
Maypharm Lifesciences Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MH-19-0031971). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website maypharm.com.
Company details
CIN U51101MH2016PTC273231
Registration Number 273231
Incorporation Date 17 February 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MH-19-0031971
Key People
Sameer Sidhram Kolhe Managing Director Ameya Anant Budukh Director Vijay Himatlal Doshi Director Recognitions & Rankings of Maypharm Lifesciences
Contact details
Maypharm Lifesciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is maypharm.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address87 Vishal Industrial Estate Opp Ceat Tyres Village Bhandup West Mumbai 400078 Mh In, Maharashtra, India – 400078
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Maypharm Lifesciences Private Limited, buy the company report.
Comprehensive company report
Maypharm Lifesciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Maypharm Lifesciences operates one associated brand: Maypharm Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers healthcare products, regulatory support, and business consulting in Latin America. | maypharm.com |
Business activity
The main business activity of Maypharm Lifesciences is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Maypharm Lifesciences Private Limited, buy the company report.
Financials of Maypharm Lifesciences Private Limited
FY 2024 filings availableMaypharm Lifesciences Private Limited reported revenue of ₹15.79 Cr (up 33% YoY) for FY 2025.
Revenue · FY 2025
₹15.79 Cr ▲ 33%
Net profit · FY 2025
₹1.58 Cr margin 10%
EBITDA · FY 2025
₹2.38 Cr margin 15.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 238%
5 years · compounded
▲ 123%
EBITDA CAGR growth
1 year
▲ 530%
3 years · compounded
▲ 49%
5 years · compounded
▲ 32%
Revenue has grown at a compounded annual rate (CAGR) of 123% over five years, including 33% growth in the latest year. EBITDA rose 530% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.38 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.58 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.1% | ||||
| Net Profit Margin | 10% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Maypharm Lifesciences Private Limited, buy the company report.
Board of directors of Maypharm Lifesciences Private Limited
Maypharm Lifesciences has 4 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ameya Anant Budukh Also directs: Maypharm Healthcare Private Limited, Zalika Pharmaceuticals Private Limited, THLC Consumer Products Private Limited and 2 more | Director | 26 Dec 2017 | 8 Years 9 Months | Current |
| Vijay Himatlal Doshi Also directs: Pharcos Speciality Limited, PNR Impex Private Limited | Director | 06 Aug 2019 | 7 Years 2 Months | Current |
| Jaynil Pankaj Doshi | Director | 06 Aug 2019 | 7 Years 2 Months | Current |
| Sameer Sidhram Kolhe | Managing Director | 17 Feb 2016 | 10 Years 8 Months | Current |
Auditor
Maypharm Lifesciences Private Limited is audited by K B L & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K B L & ASSOCIATES | FY 2023 | 138242W |
Shareholding
The shareholding of Maypharm Lifesciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Maypharm Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Maypharm Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Maypharm Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Maypharm Lifesciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AALCM2177J1Z2 | Maharashtra | Active | 12 Sep 2017 |
To see the full GST registrations and return filing status of Maypharm Lifesciences Private Limited, buy the company report.
Recent activity
Maypharm Lifesciences Private Limited has 9 board changes on record since 2016: 4 appointments and 5 cessations. The latest: Jaynil Pankaj Doshi was appointed as Director on 06 Aug 2019.
AGM
Maypharm Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Maypharm Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Jaynil Pankaj Doshi was appointed as Director.
Appointed
Vijay Himatlal Doshi was appointed as Director.
Ceased
Sameer Sidhram Kolhe ceased to be Director.
Ceased
Ameya Anant Budukh ceased to be Additional Director.
Appointed
Ameya Anant Budukh was appointed as Director.
Ceased
Yash Himansu Bapat ceased to be Director.
Ceased
Archana Mahantesh Belle ceased to be Director.
Ceased
Avinash Keshav Tiwari ceased to be Director.
Appointed
Sameer Sidhram Kolhe was appointed as Managing Director.
Incorporation
17 Feb 2016
Maypharm Lifesciences Private Limited was registered on 17 Feb 2016 with Roc Mumbai & aged 10 years 8 months as per MCA records.
News
Frequently asked questions
Maypharm Lifesciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 February 2016 (10+ years old) and is registered under CIN U51101MH2016PTC273231.
Maypharm Lifesciences has 4 current directors:
- Sameer Sidhram Kolhe - Managing Director
- Ameya Anant Budukh - Director
- Vijay Himatlal Doshi - Director
- Jaynil Pankaj Doshi - Director
The latest financial statements of Maypharm Lifesciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Maypharm Lifesciences is 27AALCM2177J1Z2, registered in Maharashtra.
The CIN (Corporate Identification Number) of Maypharm Lifesciences is U51101MH2016PTC273231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maypharm Lifesciences was incorporated on 17 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Jaynil Pankaj Doshi was appointed as Director on 06 Aug 2019. Vijay Himatlal Doshi was appointed as Director on 06 Aug 2019. Sameer Sidhram Kolhe ceased to be Director on 03 Jun 2019. Maypharm Lifesciences has 9 board changes on record in total.
Yes, Maypharm Lifesciences is registered as an MSME under Udyam registration (number: UDYAM-MH-19-0031971).
Maypharm Lifesciences can be reached through the website maypharm.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Maypharm Lifesciences is at 87 Vishal Industrial Estate Opp Ceat Tyres Village Bhandup West Mumbai 400078 Mh In, Maharashtra, India – 400078.